A novel strategy of transferring NIS protein to cells using extracellular vesicles leads to increase in iodine uptake and cytotoxicity
Open Access
- 1 March 2019
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 14, 1779-1787
Abstract
Background: This study was designed to explore a novel approach for transferring NIS protein to cells using extracellular vesicle (EV) and enhancing iodine avidity in hepatocellular carcinoma (HCC) cells. Methods: We transfected the HCC cells (Huh7) with NIS gene, designated as Huh7/NIS, and isolated the EVs from them. Presence of NIS protein in EVs and EV-mediated transport of NIS protein to recipient Huh7 cells were tested using Western blotting. We also examined radioiodine uptake in Huh7 cells treated with EV-Huh7/NIS. Results: Successful transfer of NIS protein into Huh7 cells was confirmed by WB and microscopy. EVs showed high levels of NIS protein in them. Treatment of Huh7 cells with EV-Huh7/NIS increased the NIS protein level and enhanced 125I uptake in recipient Huh7 cells. In addition, EV-huh7/NIS pre-treatment enhanced the cytotoxicity of 131I therapy against Huh7 cells by inducing increased DNA damage/increased γH2A.X foci formation. Conclusion: This is the first-of-its-kind demonstration of successful transportation of the NIS protein to cells via EVs, which increased radioiodine uptake. This approach can revert radioiodine-resistant cancers into radioiodine-sensitive cancers.Keywords
This publication has 32 references indexed in Scilit:
- Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinomaNuclear Medicine and Biology, 2013
- Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant TumorsACS Nano, 2013
- Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer CellsPLOS ONE, 2012
- Sodium Iodide Symporter for Nuclear Molecular Imaging and Gene Therapy: From Bedside to Bench and BackTheranostics, 2012
- Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activationJournal of Clinical Investigation, 2011
- Combined radionuclide–chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFPCancer Letters, 2010
- Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling PathwaysThe Journal of Clinical Endocrinology & Metabolism, 2010
- Expression, activation, and function of integrin αMβ2 (Mac-1) on neutrophil-derived microparticlesBlood, 2008
- Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophilsPlatelets, 2004
- Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroidCA: A Cancer Journal for Clinicians, 1990